Stocks · Health care · Pharmaceutical Preparations

Royalty Pharma plc

RPRX Clue Score47
United States Fiscal year ends December CIK 0001802768 Results filed 4 Nov 2026

What the insiders did No buying or selling

By person

15 insiders · 0 transactions
79.6×

Pablo Legorreta holds 79.6 times base salary in stock. $74.68M of shares against $937.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Pablo Legorreta last reported holding, valued at $57.10, the price Class A Ordinary Shares was last bought or sold at on the open market here, on 5 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Pablo G. Legorreta
CEO, Chairman of the Board
—
—
—
1,307,820
$74.68M
+1,950%
Christopher Hite
EVP & Chairman, Partnering
—
—
—
664,002
$37.91M
−10.3%
Gregory Norden
Director
—
—
—
196,348
$11.21M
+158.1%
Errol B Desouza
Director
—
—
—
81,352
$4.65M
+10.3%
Bonnie L Bassler
Director
—
—
—
79,823
$4.56M
+33.5%
Henry A Fernandez
Director
—
—
—
65,324
$3.73M
+21.0%
Ted W Love
Director
—
—
—
58,393
$3.33M
+26.3%
Catherine M. Engelbert
Director
—
—
—
55,673
$3.18M
+27.9%
David C Hodgson
Director
—
—
—
37,873
$2.16M
+47.3%
Marshall Urist
EVP, Research & Investments
—
—
—
19,020
$1.09M
−71.0%
Vlad Coric
Director
—
—
—
15,343
$876.09K
—
Elizabeth H Weatherman
Director
—
—
—
13,103
$748.18K
—
Carole Ho
Director
—
—
—
4,545
$259.52K
—
Terrance P. Coyne
EVP & CFO
—
—
—
0
$0.00
−100.0%
George W. Lloyd
EVP, Investments & CLO
—
—
—
0
$0.00
−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.